Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

Article  PubMed  Google Scholar 

Onitilo AA, Engel JM, Greenlee RT, Mukesh BN (2009) Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 7(1–2):4–13

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eliyatkın N, Yalçın E, Zengel B, Aktaş S, Vardar E (2015) Molecular classification of breast carcinoma: from traditional, old-fashioned way to a new age, and a new way. J Breast Health 11(2):59–66

Article  PubMed  PubMed Central  Google Scholar 

Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312(3):146–151

Article  CAS  PubMed  Google Scholar 

Neal L, Sandhu NP, Hieken TJ, Glazebrook KN, Mac Bride MB, Dilaveri CA et al (2014) Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. Mayo Clin Proc 89(4):536–547

Article  PubMed  Google Scholar 

Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K (2015) Atypical hyperplasia of the breast–risk assessment and management options. N Engl J Med 372(1):78–89

Article  PubMed  PubMed Central  Google Scholar 

Cuzick J, Sestak I, Thorat MA (2015) Impact of preventive therapy on the risk of breast cancer among women with benign breast disease. Breast Edinb Scotl 24(Suppl 2):S51-55

Article  Google Scholar 

Figueroa JD, Gierach GL, Duggan MA, Fan S, Pfeiffer RM, Wang Y et al (2021) Risk factors for breast cancer development by tumor characteristics among women with benign breast disease. Breast Cancer Res 23(1):34

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y et al (2017) Role of tumor microenvironment in tumorigenesis. J Cancer 8(5):761–773

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soysal SD, Tzankov A, Muenst SE (2015) Role of the tumor microenvironment in breast cancer. Pathobiology 82(3–4):142–152

Article  CAS  PubMed  Google Scholar 

Mittal S, Brown NJ, Holen I (2018) The breast tumor microenvironment: role in cancer development, progression and response to therapy. Expert Rev Mol Diagn 18(3):227–243

Article  CAS  PubMed  Google Scholar 

Mehraj U, Dar AH, Wani NA, Mir MA (2021) Tumor microenvironment promotes breast cancer chemoresistance. Cancer Chemother Pharmacol 87(2):147–158

Article  PubMed  Google Scholar 

Folgueira MAAK, Maistro S, Katayama MLH, Roela RA, Mundim FGL, Nanogaki S et al (2013) Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series. Biosci Rep 33(6):e00085

Article  PubMed  PubMed Central  Google Scholar 

Knower KC, Chand AL, Eriksson N, Takagi K, Miki Y, Sasano H et al (2013) Distinct nuclear receptor expression in stroma adjacent to breast tumors. Breast Cancer Res Treat 142(1):211–223

Article  CAS  PubMed  Google Scholar 

Cid S, Eiro N, Fernández B, Sánchez R, Andicoechea A, Fernández-Muñiz PI et al (2018) Prognostic influence of tumor stroma on breast cancer subtypes. Clin Breast Cancer 18(1):e123–e133

Article  CAS  PubMed  Google Scholar 

Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL et al (2020) Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. J Clin Oncol Off J Am Soc Clin Oncol 38(12):1346–1366

Article  Google Scholar 

Shao ZM, Nguyen M, Barsky SH (2000) Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19(38):4337–4345

Article  CAS  PubMed  Google Scholar 

Hilton HN, Clarke CL, Graham JD (2018) Estrogen and progesterone signalling in the normal breast and its implications for cancer development. Mol Cell Endocrinol 5(466):2–14

Article  Google Scholar 

Lamb CA, Fabris VT, Jacobsen BM, Molinolo A, Lanari C (2018) Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer. Endocr Relat Cancer 25(12):R605–R624

Article  CAS  Google Scholar 

Hopp TA, Weiss HL, Hilsenbeck SG, Cui Y, Allred DC, Horwitz KB et al (2004) Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates. Clin Cancer Res 10(8):2751–2760

Article  CAS  PubMed  Google Scholar 

Calhoun BC, Mosteller B, Warren D, Smith M, Jordi Rowe J, Lanigan CP et al (2018) Analytical and clinical performance of progesterone receptor antibodies in breast cancer. Ann Diagn Pathol 1(35):21–26

Article  Google Scholar 

Booth ME, Hanby AM, Speirs V (2014) Steroid hormone receptor expression in breast cancer stroma. Breast Cancer Res Treat 143(3):605–607

Article  PubMed  Google Scholar 

Creighton CJ, Osborne CK, van de Vijver MJ, Foekens JA, Klijn J, Horlings HM et al (2009) Molecular profiles of progesterone receptor loss in human breast tumors. Breast Cancer Res Treat 114(2):287–299

Article  CAS  PubMed  Google Scholar 

Prat A, Cheang MCU, Martín M, Parker JS, Carrasco E, Caballero R et al (2013) Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal a breast cancer. J Clin Oncol 31(2):203–209

Article  CAS  PubMed  Google Scholar 

O’Neill JS, Miller WR (1987) Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases. Br J Cancer 56(5):601–604

Article  PubMed  PubMed Central  Google Scholar 

Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R et al (1996) Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab 81(11):4042–4046

CAS  PubMed  Google Scholar 

Santen RJ, Santner SJ, Pauley RJ, Tait L, Kaseta J, Demers LM et al (1997) Estrogen production via the aromatase enzyme in breast carcinoma: which cell type is responsible? J Steroid Biochem Mol Biol 61(3–6):267–271

Article  CAS  PubMed  Google Scholar 

Chen X, Li J, Gray WH, Lehmann BD, Bauer JA, Shyr Y, Pietenpol JA (2012) TNBCtype: a subtyping tool for triple-negative breast cancer. Cancer Informatics 11:147–153

Article  PubMed  PubMed Central  Google Scholar 

Lehmann BD, Pientenpol JA (2014) Identification and use of biomarkers in treatment strategies for triple negative breast cancer subtypes. J Pathol 232(2):142–150

Article  PubMed  PubMed Central  Google Scholar 

Li Q, Eklund AC, Juul N, Haibe-Kains B, Workman CT, Richardson AL et al (2010) Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status. PLoS ONE 5(12):e15031

Article  CAS  PubMed  PubMed Central  Google Scholar 

Troxell ML, Long T, Hornick JL, Ambaye AB, Jensen KC (2017) Comparison of estrogen and progesterone receptor antibody reagents using proficiency testing data. Arch Pathol Lab Med 141(10):1402–1412

Article  CAS  PubMed  Google Scholar 

Khoury T (2018) Delay to formalin fixation (Cold Ischemia Time) effect on breast cancer molecules. Am J Clin Pathol 149(4):275–292

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif